ArticlePharmaceutics2024

Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment.

Su Yeon Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.